On this episode of Benefits Companion, host Brydon DeWitt talks with Sarah Parker of SageView Advisory Group about the growing interest in private markets within defined contribution retirement plans. They explore what "private markets" really mean, why more plan sponsors are considering them, and how these investments could impact participants' long-term outcomes. Whether you're a plan sponsor, fiduciary, or benefits professional, this episode offers insights into the opportunities and complexities of integrating private markets into defined contribution plans.

On this episode of Benefits Companion, host Brydon DeWitt talks with Caroline Susie of MercerWELL about the rise of GLP-1 medications. They discuss how these drugs work, why they're transforming weight loss, and the tough questions employers face—from whether to cover them, to managing costs, to what else is needed to best support a healthier workforce. Whether you're an HR leader, benefits administrator, or simply curious about the changing landscape of employee health, this episode offers practical guidance on navigating one of the most pressing topics in workforce benefits today.

With growing interest in alternative investments—from private equity and digital assets to ESG—defined contribution plan sponsors face both fresh opportunities and heightened scrutiny. In this episode of Williams Mullen's Benefits Companion, Brydon DeWitt is joined by Beryl Ball, Principal Financial Advisor at CAPTRUST, to explore how plan sponsors can assess these emerging asset classes, weigh participant demand, and use tools such as self-directed brokerage windows. They also examine the implications of President Trump's August 7, 2025, executive order, which directs the Department of Labor, SEC, and Treasury to revisit ERISA guidance, develop potential safe harbors, and lower litigation risks for offering alternatives in 401(k) plans.